UPDATE 1-U.S. watchdog told Medicare, Medicaid that EpiPen was misclassified in 2009 -senator

WASHINGTON, Nov 8 (Reuters) - The internal watchdog at the

U.S. Department of Health and Human Services warned the office

tasked with administering federal health insurance programs that

Mylan NV's EpiPen was improperly classified as a generic

drug in 2009, Senator Charles Grassley said Tuesday.

Read more